View in EDS PDF Full Text

Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters.

Saved in:
Bibliographic Details
Title: Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters.
Authors: Abdelnabi R; Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology, Molecular Vaccinology and Vaccine Discovery, KU Leuven, Leuven, Belgium., Pérez P; Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain., Astorgano D; Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain., Albericio G; Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain., Kerstens W; Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Translational Platform Virology and Chemotherapy, KU Leuven, Leuven, Belgium., Thibaut HJ; Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Translational Platform Virology and Chemotherapy, KU Leuven, Leuven, Belgium., Coelmont L; Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology, Molecular Vaccinology and Vaccine Discovery, KU Leuven, Leuven, Belgium., Weynand B; Department of Imaging and Pathology, Translational Cell and Tissue Research, Division of Translational Cell and Tissue Research, KU Leuven, Leuven, Belgium., Labiod N; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain., Delgado R; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Medicine, Medical School, Universidad Complutense de Madrid, Madrid, Spain., Montenegro D; Biofabri, O Porriño, Pontevedra, Spain., Puentes E; Biofabri, O Porriño, Pontevedra, Spain., Rodríguez E; Biofabri, O Porriño, Pontevedra, Spain., Neyts J; Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology, Molecular Vaccinology and Vaccine Discovery, KU Leuven, Leuven, Belgium., Dallmeier K; Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology, Molecular Vaccinology and Vaccine Discovery, KU Leuven, Leuven, Belgium., Esteban M; Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain., García-Arriaza J; Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.
Source: Frontiers in immunology [Front Immunol] 2023 Oct 18; Vol. 14, pp. 1163159. Date of Electronic Publication: 2023 Oct 18 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37920464
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Abdelnabi+R%22">Abdelnabi R</searchLink>; Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology, Molecular Vaccinology and Vaccine Discovery, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Pérez+P%22">Pérez P</searchLink>; Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Astorgano+D%22">Astorgano D</searchLink>; Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Albericio+G%22">Albericio G</searchLink>; Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Kerstens+W%22">Kerstens W</searchLink>; Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Translational Platform Virology and Chemotherapy, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Thibaut+HJ%22">Thibaut HJ</searchLink>; Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Translational Platform Virology and Chemotherapy, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Coelmont+L%22">Coelmont L</searchLink>; Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology, Molecular Vaccinology and Vaccine Discovery, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Weynand+B%22">Weynand B</searchLink>; Department of Imaging and Pathology, Translational Cell and Tissue Research, Division of Translational Cell and Tissue Research, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Labiod+N%22">Labiod N</searchLink>; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Delgado+R%22">Delgado R</searchLink>; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Medicine, Medical School, Universidad Complutense de Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Montenegro+D%22">Montenegro D</searchLink>; Biofabri, O Porriño, Pontevedra, Spain.<br /><searchLink fieldCode="AU" term="%22Puentes+E%22">Puentes E</searchLink>; Biofabri, O Porriño, Pontevedra, Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez+E%22">Rodríguez E</searchLink>; Biofabri, O Porriño, Pontevedra, Spain.<br /><searchLink fieldCode="AU" term="%22Neyts+J%22">Neyts J</searchLink>; Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology, Molecular Vaccinology and Vaccine Discovery, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Dallmeier+K%22">Dallmeier K</searchLink>; Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology, Molecular Vaccinology and Vaccine Discovery, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Esteban+M%22">Esteban M</searchLink>; Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22García-Arriaza+J%22">García-Arriaza J</searchLink>; Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2023 Oct 18; Vol. 14, pp. 1163159. <i>Date of Electronic Publication: </i>2023 Oct 18 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37920464
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2023.1163159
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1163159
    Titles:
      – TitleFull: Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Abdelnabi R
      – PersonEntity:
          Name:
            NameFull: Pérez P
      – PersonEntity:
          Name:
            NameFull: Astorgano D
      – PersonEntity:
          Name:
            NameFull: Albericio G
      – PersonEntity:
          Name:
            NameFull: Kerstens W
      – PersonEntity:
          Name:
            NameFull: Thibaut HJ
      – PersonEntity:
          Name:
            NameFull: Coelmont L
      – PersonEntity:
          Name:
            NameFull: Weynand B
      – PersonEntity:
          Name:
            NameFull: Labiod N
      – PersonEntity:
          Name:
            NameFull: Delgado R
      – PersonEntity:
          Name:
            NameFull: Montenegro D
      – PersonEntity:
          Name:
            NameFull: Puentes E
      – PersonEntity:
          Name:
            NameFull: Rodríguez E
      – PersonEntity:
          Name:
            NameFull: Neyts J
      – PersonEntity:
          Name:
            NameFull: Dallmeier K
      – PersonEntity:
          Name:
            NameFull: Esteban M
      – PersonEntity:
          Name:
            NameFull: García-Arriaza J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 10
              Text: 2023 Oct 18
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1